One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
732 524 0400
https://www.jnj.com
Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full Time Employees: 152,700
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Joaquin Duato | CEO & Chairman | 4.84M | 8.65M | 1963 |
Mr. Joseph J. Wolk CPA | Executive VP & CFO | 2.26M | 1.35M | 1967 |
Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Pharmaceuticals | 2.16M | 8.02M | 1964 |
Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer | N/A | N/A | 1972 |
Mr. James Swanson | Executive VP & Chief Information Officer | N/A | N/A | 1966 |
Ms. Jessica Moore | Vice President of Investor Relations | N/A | N/A | N/A |
Mr. Dirk Brinckman | Chief Compliance Officer | N/A | N/A | N/A |
Ms. Elizabeth Forminard | Executive VP & General Counsel | N/A | N/A | 1971 |
Dr. Peter M. Fasolo Ph.D. | Executive VP & Chief Human Resources Officer | 1.28M | N/A | 1963 |
Dr. Guy J. Lebeau M.D. | Group Chairman of MD&D Business - EMEA | N/A | N/A | N/A |
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Johnson & Johnson’s ISS Governance QualityScore as of December 1, 2023 is 2. The pillar scores are Audit: 6; Board: 4; Shareholder Rights: 2; Compensation: 3.